Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-12

FDA Approved: VELSIPITY — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved VELSIPITY (etrasimod) from Pfizer as a new therapy for ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VELSIPITY (ETRASIMOD)

Snippet

ORIG AP for VELSIPITY (ETRASIMOD)